> Investors > 

News Releases

Date Title  
Toggle Summary ACETO Appoints Edward J. Borkowski Chief Financial Officer
PORT WASHINGTON, N.Y. , Feb. 16, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Edward J. 
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25mg, 50mg and 100mg
PORT WASHINGTON, N.Y. , Feb. 07, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 Second Quarter Results Printer Friendly Version
Toggle Summary ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y. , Feb. 01, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that its Board of
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules Second Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Efavirenz Capsules, 50mg and 200mg
PORT WASHINGTON, N.Y. , Jan. 02, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y. , Dec. 07, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), focused on the global development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that its Board of Directors has declared a
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 First Quarter Results
PORT WASHINGTON, N.Y. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml
PORT WASHINGTON, N.Y. , Oct. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Oct. 20, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
top